Structure, function and amyloidogenic propensity of apolipoprotein A-I
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis in Amyloid
- Vol. 13 (4) , 191-205
- https://doi.org/10.1080/13506120600960288
Abstract
Apolipoprotein A-I, the major structural apolipoprotein of high-density lipoproteins, efficiently protects humans from cholesterol accumulation in tissues; however, it can cause systemic amyloidosis in the presence of peculiar amino acid replacements. The wild-type molecule also has an intrinsic tendency to generate amyloid fibrils that localise within the atherosclerotic plaques. The structure, folding and metabolism of normal apolipoprotein A-I are extremely complex and as yet not completely clarified, but their understanding appears essential for the elucidation of the amyloid transition. We reviewed present knowledge on the structure, function and amyloidogenic propensity of apolipoprotein A-I with the aim of highlighting the possible molecular mechanisms that might contribute to the pathogenesis of this disease. Important clues on apolipoprotein A-I amyloidogenesis may be obtained from classical comparative studies of the properties of the wild-type versus the amyloidogenic counterpart. Additionally, in the case of apoA-I, further insights on the molecular mechanisms underlying its amyloidogenic propensity may derive from comparative studies between amyloidogenic variants and other mutations associated with hypoalphalipoproteinemia without amyloidosis.Keywords
This publication has 82 references indexed in Scilit:
- Renal Apolipoprotein A-I AmyloidosisJournal of the American Society of Nephrology, 2005
- Ostertag revisited: The inherited systemic amyloidoses without neuropathyAmyloid, 2005
- Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of AmyloidosisAmyloid, 2005
- Molecular Mechanisms of AmyloidosisNew England Journal of Medicine, 2003
- Pathology, diagnosis and pathogenesis of AA amyloidosisVirchows Archiv, 2002
- Sub‐micellar phospholipid accelerates amyloid formation by apolipoprotein C‐IIFEBS Letters, 2001
- Apolipoprotein AI and Transthyretin as Components of Amyloid Fibrils in a Kindred with apoAI Leu178His AmyloidosisThe American Journal of Pathology, 2000
- Testicular amyloid deposition as a cause of secondary azoospermiaUrology, 2000
- The New Apolipoprotein A-I Variant Leu174 → Ser Causes Hereditary Cardiac Amyloidosis, and the Amyloid Fibrils Are Constituted by the 93-Residue N-Terminal PolypeptideThe American Journal of Pathology, 1999
- Hereditary Amyloid Cardiomyopathy Caused by a Variant Apolipoprotein A1The American Journal of Pathology, 1999